Journey Medical Corp. (DERM)
3.30
-0.25
(-7.04%)
USD |
NASDAQ |
Nov 20, 16:00
3.30
0.00 (0.00%)
After-Hours: 20:00
Journey Medical Research and Development Expense (TTM) : 0.259M for Sept. 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.259M |
| June 30, 2026 | 0.495M |
| March 31, 2026 | 0.441M |
| December 31, 2025 | 0.48M |
| September 30, 2025 | 0.544M |
| June 30, 2025 | 1.099M |
| March 31, 2025 | 2.012M |
| December 31, 2024 | 9.857M |
| September 30, 2024 | 11.14M |
| June 30, 2024 | 12.53M |
| March 31, 2024 | 13.39M |
| December 31, 2023 | 7.541M |
| Date | Value |
|---|---|
| September 30, 2023 | 10.29M |
| June 30, 2023 | 10.88M |
| March 31, 2023 | 11.71M |
| December 31, 2022 | 10.94M |
| September 30, 2022 | 8.679M |
| June 30, 2022 | 6.661M |
| March 31, 2022 | 17.82M |
| December 31, 2021 | 16.56M |
| September 30, 2021 | 14.57M |
| June 30, 2021 | 13.77M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Talphera, Inc. | 7.09M |
| Fortress Biotech, Inc. | 2.656M |
| Relmada Therapeutics, Inc. | 33.77M |
| Turn Therapeutics, Inc. | 1.225M |
| ANI Pharmaceuticals, Inc. | 50.60M |